Largest Clinical-Stage BioTech Drug Stocks Declined 6%
June 22, 2024 at 19:16 PM EDT
Of the 10 clinical-stage AI-focused and psychedelic compound-based small cap drug discovery companies in our Clinical-Stage BioTech Drug Stocks Portfolio, only 1 advanced this week. On average they were down 6% last week and -21.6% YTD.
